“…1). While LPS and Poly(I:C) elicit distinct molecular profiles -targeting the toll-like receptor (TLR) 4 and TLR3 pathways respectively -both MIA paradigms have been successfully used to establish animal models for some of the most common and debilitating neuropsychiatric disorders, including schizophrenia, autism and depression (Fatemi et al, 1999;Fatemi et al, 2002aFatemi et al, , 2002bFatemi et al, 2002b;Smith et al, 2007;Garbett et al, 2012;Dickerson & Bilkey, 2013;Bauman et al, 2014;Khan et al, 2014). Despite continuous efforts, the neurobiological basis of these severe mental illnesses, which compromise the quality of life of patients and their families as well as posing significant socioeconomic burden on society (Kessler et al, 2003), remain incompletely understood currently available pharmacotherapeutic options present with major limitations: they provide relief from only some of the symptoms and fail to cure the respective disorders, are effective only in a limited number of affected patients, Fig.…”